PLoS Pathogens (Sep 2020)

Determination of a novel parvovirus pathogen associated with massive mortality in adult tilapia.

  • Wenzhi Liu,
  • Yecheng Zhang,
  • Jie Ma,
  • Nan Jiang,
  • Yuding Fan,
  • Yong Zhou,
  • Kenneth Cain,
  • Meisheng Yi,
  • Kuntong Jia,
  • Hua Wen,
  • Wei Liu,
  • Wuxiang Guan,
  • Lingbing Zeng

DOI
https://doi.org/10.1371/journal.ppat.1008765
Journal volume & issue
Vol. 16, no. 9
p. e1008765

Abstract

Read online

Tilapia is one of the most important economic and fastest-growing species in aquaculture worldwide. In 2015, an epidemic associated with severe mortality occurred in adult tilapia in Hubei, China. The causative pathogen was identified as Tilapia parvovirus (TiPV) by virus isolation, electron microscopy, experimental challenge, In situ hybridization (ISH), indirect immunofluorescence (IFA), and viral gene sequencing. Electron microscopy revealed large numbers of parvovirus particles in the organs of diseased fish, including kidney, spleen, liver, heart, brain, gill, intestine, etc. The virions were spherical in shape, non-enveloped and approximately 30nm in diameter. The TiPV was isolated and propagated in tilapia brain cells (TiB) and induced a typical cytopathic effect (CPE) after 3 days post-infection (dpi). This virus was used to experimentally infect adult tilapia and clinical disease symptoms similar to those observed naturally were replicated. Additionally, the results of ISH and IFA showed positive signals in kidney and spleen tissues from TiPV-infected fish. To identify TiPV-specific sequences, the near complete genome of TiPV was obtained and determined to be 4269 bp in size. Phylogenetic analysis of the NS1 sequence revealed that TiPV is a novel parvovirus, forms a separate branch in proposed genus Chapparvovirus of Parvoviridae. Results presented here confirm that TiPV is a novel parvovirus pathogen that can cause massive mortality in adult tilapia. This provides a basis for the further studies to define the epidemiology, pathology, diagnosis, prevention and treatment of this emerging viral disease.